CMS Uses Advanced Analytics to Target Fraudulent Medicare Laboratory Billing

Published Date: 10/1/2026
On August 28, 2026, the Centers for Medicare & Medicaid Services (CMS) announced that its enforcement efforts had stopped more than $1.6 billion in potentially improper Medicare laboratory payments since the beginning of 2025. The figure includes $732 million in estimated savings from terminating 157 laboratory providers from the Medicare program, more than $500 million in potentially fraudulent payments halted through payment suspensions involving 185 laboratories, more than $276 million in overpayments recovered from 442 laboratories, and $127 million in potentially fraudulent payments prevented following 85 law-enforcement referrals. CMS said the actions targeted billing patterns, including claims for laboratory services that were not performed, medically unnecessary testing, upcoding, and testing for patients who had no established relationship with the ordering provider.
Related Practices: Healthcare Law, Litigation
Related Attorney: Keith J. Roberts, Shannon Carroll, Paul J. DeMartino, Jr.
Related Industry: Healthcare









